Tag: Hydroxychloroquine

In a clinical trial testing whether a daily regimen of hydroxychloroquine could protect those most likely to be exposed to COVID-19, researchers from the Perelman School of Medicine at the University of Pennsylvania found there was no difference in infection rates among health care workers who took the drug versus those taking a placebo. While

A new review published in Frontiers in Public Health suggests that COVID-19, the illness caused by the SARS-CoV-2 virus, will likely become seasonal in countries with temperate climates, but only when herd immunity is attained. Until that time, COVID-19 will continue to circulate across the seasons. These conclusions highlight the absolute importance of public health

Anti-malaria drug hydroxychloroquine taken by Trump does NOT protect people from developing COVID-19 after they have been exposed to someone with the illness, study finds Researchers gave hydroxychloroquine to half of a group of 821 people who had been exposed to coronavirus and the other half a placebo regimen  Of the 107 people who fell

Drug for treatment of COVID-19 poses a risk for serious side effects Hydroxychloroquine is a drug approved for the treatment of Malaria. Currently, the drug is also used against COVID-19. This is not harmless, because in studies of the Mediterranean, with serious, in some cases, fatal cardiac arrhythmias have been brought in connection. The Federal

(HealthDay)—Hydroxychloroquine (HCQ) can shorten time to clinical recovery and promote pneumonia absorption among patients with coronavirus disease 2019 (COVID-19), according to a study that has not yet been peer reviewed and was posted online March 31 at medRxiv.org. Zhaowei Chen, from the Renmin Hospital of Wuhan University in China, and colleagues examined the efficacy of